Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
Centro de Investigación Biomedica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain.
Asia Pac J Ophthalmol (Phila). 2022;11(2):160-167. doi: 10.1097/APO.0000000000000510.
Retinal neurodegeneration plays a significant role in the pathogenesis of diabetic retinopathy, the leading cause of preventable blindness. The hallmarks of diabetes-induced neurodegeneration are neural cell apoptosis and glial activation, which seem even before vascular lesions can be detected by ophthalmoscopic examination. The molecular mediators of retinal neurodegeneration include proinflamma- tory cytokines, oxidative stress, mitochondrial dysfunction, and the molecular pathways closely related to chronic hyperglycemia. In this article, an overview of the main components of neurodegeneration, its key underlying mechanisms, and the more useful experimental models for investigative purposes will be given. In addition, the results of most relevant treatments based on neuroprotection, and the research gaps that should be filled will be critically reviewed.
视网膜神经退行性变在糖尿病性视网膜病变(导致可预防失明的主要原因)的发病机制中起着重要作用。糖尿病引起的神经退行性变的特征是神经细胞凋亡和神经胶质细胞激活,甚至在眼科检查可以检测到血管病变之前就已经出现了。视网膜神经退行性变的分子介质包括促炎细胞因子、氧化应激、线粒体功能障碍以及与慢性高血糖密切相关的分子途径。本文将概述神经退行性变的主要成分、其关键潜在机制以及更有用的实验模型,以用于研究目的。此外,还将批判性地回顾基于神经保护的最相关治疗的结果以及应该填补的研究空白。